U.S. Auto Stock News

Talen Energy has delivered a very large gain over the past three years, yet the share price has recently pulled back and the valuation checks now point to a mixed picture rather than a clear bargain or clear overpricing. Over the past three years, Talen Energy is up very sharply, which puts the current weakness into the context of a powerful earlier recovery. Future valuation can depend on how reliably the business converts its asset base into cash flow. Any setback in execution or higher...

Lam Research (LRCX) is back in focus after Barometer Capital Management flagged the stock as a key positive contributor in Q2 2026, citing strong exposure to memory equipment tied to AI demand. Lam Research shares have cooled in recent weeks, with the 30-day share price return down 8.6% and the 90-day move down 18.7%. The stock still carries a strong year to date share price gain of 61.2% and a one year total shareholder return of 156.4%. Momentum has therefore eased near the US$298.22 level...

Caterpillar (NYSE:CAT) introduced the Cat D11 XE electric-drive dozer, highlighting gains in fuel efficiency, productivity, and emissions performance. The firm reported record power and energy sales, tied to strong data center demand and changing preferences in generator technology. Management linked results to a shift toward hybrid and battery-integrated generator systems in the global power market. The Cat D11 XE launch and record power and energy performance sit within wider shifts our...

Kulicke and Soffa Industries (KLIC) just put its Thermo Compression Bonding and fluxless packaging technology in the spotlight as the semiconductor sector leans into Co Packaged Optics for AI focused networking and data center hardware. Recent trading has reflected that story. Kulicke and Soffa Industries has seen the share price climb 3.75% over the last day and 5.48% across the week, yet pull back 9.53% over 30 days and 23.91% over 90 days. A 78.05% year to date share price return and...

InterDigital’s latest damages claim against Walt Disney (DIS), seeking €101.7 million over streaming video patents after several European injunctions, has pushed legal risk around Disney’s direct to consumer platforms back into focus. Disney’s legal setback lands at a tricky moment for the stock, with the 90 day share price return of 6.5% and 30 day gain of 3.2% contrasting with a year to date share price decline of 4.7%. Legal headlines, new content like National Geographic’s upcoming AFRICA...

Willis Towers Watson (WTW) has put AI execution in sharper focus after announcing a partnership with Lyzr, aiming to help clients embed agentic AI workflows directly into everyday operations and workforce decisions. Recent trading shows a mixed picture for Willis Towers Watson. The share price is US$315.61 after a 7 day decline of 5.71% and a 30 day fall of 7.25%. However, the 90 day share price return of 20.17% and 3 year total shareholder return of 59.87% point to momentum that has built...

Laureate Education (LAUR) most recently closed at $36.14, drawing fresh attention from investors reviewing education stocks after a period of mixed short term returns and a stronger performance over the past year. The recent 1-day share price gain of 1.02% comes after softer 7-day and 30-day share price returns. Laureate Education’s 1-year total shareholder return of 22.97% and very large 5-year total shareholder return of about 3.4x suggest longer term momentum has been much stronger than...

STAAR Surgical (NasdaqGM:STAA) released a global market report on 12 September 2026 on vision correction procedure trends. The study highlights a structural shift in multiple regions away from laser eye surgery toward implantable lens correction using phakic ICLs. STAAR Surgical reports that surgeons and patients show growing interest in reversible procedures that are presented as carrying safety advantages. This fresh data on a move from laser to implantable lens correction should not be...

IBEX just jumped 6.8% to about $39.80, which indicates that traders reacted positively to the headline. The company reported record full year revenue of $644.1m and adjusted earnings per share of $3.52, while holding a net cash position of roughly $30.9m. In the short term, this reflects a relief pop after a stronger than usual quarter. For anyone with a longer time horizon measured in years rather than days, the combination of rising revenue and improving profitability is an important part...

QUALCOMM (QCOM) under CEO Cristiano Amon is intensifying investment in 6G research, AI data centers, robotics, and edge computing. The company is highlighting new use cases for 6G such as integrated sensing along with AI applications in smart infrastructure and national security. Management is framing this shift as a move beyond mobile devices toward broader wireless and AI-enabled markets. QUALCOMM's 6G and AI expansion push under Cristiano Amon comes alongside wider shifts our research has...

Central banks are hinting at interest rate shifts while trade policy keeps markets on edge, and that mix can quickly reward or punish global cyclical growth stocks exposed to these crosswinds. Miss the right stories and you risk watching others catch the upside in real time. This article explains how this backdrop connects to three specific stocks from our Global Cyclical Growth Stocks screener and why their reactions to the news deserve a closer look. The three stocks highlighted below are...

Flotek Industries has delivered a very large 3 year return, yet its current valuation checks lean expensive, so anyone looking at the stock today has to weigh strong recent gains against a weaker value score. Over the past 3 years, Flotek Industries has returned roughly 7x, which puts recent enthusiasm in sharp contrast with the cautious read from broader valuation metrics. Stronger expectations around international chemistry sales can support the current share price, while any...

EchoStar has delivered a very large 3 year gain, yet both its intrinsic value estimate and market multiples currently point to a stock that trades at a premium to what the underlying cash flows might support. For anyone watching EchoStar today, price action and valuation checks are pulling in the same direction, toward a richer market tag. The share price return over the past 3 years is about 396%, which puts recent strength front and center for anyone assessing what is already priced...

Zimmer Biomet Holdings stock has had a difficult run over the past few years, yet the current valuation checks still lean toward the shares being cheap rather than expensive. The question for you is whether a weak long term share price record is masking an opportunity or simply reflecting the underlying business reality. Over the past 5 years, Zimmer Biomet Holdings has declined about 31.4%, which suggests investors have been cautious on the stock for a sustained period. Recent leadership...

1-800-FLOWERS.COM stock barely budged on the results, slipping less than 1% and leaving the share price near US$3 after a tough year where the chart has steadily ground lower. The market shrugged; the income statement did not. Quarterly revenue came in around US$293 million while the business posted another sizeable net loss, keeping the trailing twelve month earnings in the red. For short term traders, it looks like more of the same. Long term holders are staring at a different puzzle, with...

TransDigm Group stock has pulled back in recent months, yet the current share price still sits well above where it traded five years ago. A Discounted Cash Flow (DCF) intrinsic value estimate points to a material gap against the market price. With broader valuation checks sending a mixed signal rather than a clear cheap or expensive label, investors are left weighing a rich long term share performance against what the cash flow math suggests today. Over the past 5 years, TransDigm Group has...

Nike (NYSE:NKE) launched a $NKE stock token on the Solana blockchain through Sunrise, opening onchain access to its equity. The tokenized format allows crypto-native investors to trade exposure to Nike shares through Solana-based decentralized finance platforms. Sunrise acts as the onchain venue for $NKE token activity, connecting traditional equity exposure with Solana wallets and trading tools. Nike's move to issue a $NKE stock token on Solana through Sunrise fits into a wider shift toward...

BETA Technologies (BETA) is back in focus after helping launch America’s Consortium for Electric Skyways, a Texas-focused eVTOL charging effort tied to the White House’s integration pilot program, along with a fresh appearance at Jefferies’ Global Industrials Conference. Investors have reacted quickly to the ACES announcement and conference exposure, with BETA Technologies’ share price rising 6.44% on a 1 day basis to US$21.17, even though the 30 day share price return is down 10.98% and the...

Lovesac stock eased 2.5% to US$13.91 into Friday’s close, which looks tame given how emotionally charged furniture earnings can get. The headline is simple. The company printed a profitable Q2 on paper, with US$0.51 in earnings per share and US$7.4m of net income, but that picture leans heavily on a one time US$21m tariff refund. When that refund is excluded, the quarter tilts back toward an adjusted EBITDA loss. Traders appear conflicted. The mild price dip signals fatigue, while the...

Skyward Specialty Insurance Group (NasdaqGS:SKWD) reports that the integration of Apollo is creating a new fee-based earnings stream. Management describes the Apollo unit as materially additive to overall earnings, shifting part of the business toward fee-driven revenue. The integration is expected to change Skyward Specialty Insurance Group's revenue mix, with a larger share tied to recurring fee income. This new Apollo fee-based earnings stream is an important shift to weigh against the...

IDEAYA Biosciences (NasdaqGS: IDYA) and Servier have dosed the first patient in the OptimUM-11 global Phase 3 trial. OptimUM-11 is evaluating darovasertib plus crizotinib as adjuvant therapy for primary uveal melanoma patients at high risk of metastasis. The study is described as the first global registrational trial of this drug combination in the adjuvant setting for primary uveal melanoma. The launch of the OptimUM-11 Phase 3 darovasertib and crizotinib adjuvant trial is a key development...

FactSet Research Systems (FDS) recently revised its debt structure through an amendment to its existing credit agreement, extending key maturities and expanding revolving commitments to support future funding flexibility. Recent trading has been rough for FactSet Research Systems, with the share price down 14% over the past week and 6.6% over the last month, even though the 90-day share price return is still up 7.7% and the 1-year total shareholder return is lower by 26.9%. This points to...

THOR Industries announced a broad reshuffle of its North American RV leadership, with Ken Walters now heading North American RV operations, new presidents installed at Jayco and Keystone, and fresh appointments in marketing and finance to support the updated operating model. The creation of a dedicated North American RV leadership layer, including a group CFO and CMO, signals a push for tighter coordination across brands, sharper cost control, and more unified marketing in a highly...

Melco Resorts & Entertainment (NasdaqGS:MLCO) has drawn attention after recent trading left the share price at $5.05. Investors are weighing this casino operator’s global footprint against a series of weak recent return figures. Recent trading tells a mixed story for Melco Resorts & Entertainment. The 1-day share price return of 0.8% contrasts with a 30-day share price return down 8.5% and a 1-year total shareholder return down 47.4%. This points to fading momentum as investors reassess both...